Matarese Valerie
UpTo Infotechnologies, Vidor (TV), Italy.
PLoS One. 2008 Jul 2;3(7):e2512. doi: 10.1371/journal.pone.0002512.
The quality of biomedical reporting is guided by statements of several organizations. Although not all journals adhere to these guidelines, those that do demonstrate "editorial leadership" in their author community. To investigate a possible relationship between editorial leadership and journal quality, research journals from two European countries, one Anglophone and one non-Anglophone, were studied and compared. Quality was measured on a panel of bibliometric parameters while editorial leadership was evaluated from journals' instructions to authors.
METHODOLOGY/PRINCIPAL FINDINGS: The study considered all 76 Italian journals indexed in Medline and 76 randomly chosen UK journals; only journals both edited and published in these countries were studied. Compared to UK journals, Italian journals published fewer papers (median, 60 vs. 93; p = 0.006), less often had online archives (43 vs. 74; p<0.001) and had lower median values of impact factor (1.2 vs. 2.7, p<0.001) and SCImago journal rank (0.09 vs. 0.25, p<0.001). Regarding editorial leadership, Italian journals less frequently required manuscripts to specify competing interests (p<0.001), authors' contributions (p = 0.005), funding (p<0.001), informed consent (p<0.001), ethics committee review (p<0.001). No Italian journal adhered to COPE or the CONSORT and QUOROM statements nor required clinical trial registration, while these characteristics were observed in 15%-43% of UK journals (p<0.001). At multiple regression, editorial leadership predicted 37.1%-49.9% of the variance in journal quality defined by citation statistics (p<0.0001); confounding variables inherent to a cross-cultural comparison had a relatively small contribution, explaining an additional 6.2%-13.8% of the variance.
CONCLUSIONS/SIGNIFICANCE: Journals from Italy scored worse for quality and editorial leadership than did their UK counterparts. Editorial leadership predicted quality for the entire set of journals. Greater appreciation of international initiatives to improve biomedical reporting may help low-quality journals achieve higher status.
生物医学报告的质量受多个组织声明的指导。尽管并非所有期刊都遵循这些指南,但遵循指南的期刊在其作者群体中展现出“编辑领导力”。为了研究编辑领导力与期刊质量之间可能存在的关系,对来自两个欧洲国家(一个英语国家和一个非英语国家)的研究期刊进行了研究和比较。质量通过一组文献计量参数来衡量,而编辑领导力则根据期刊给作者的投稿须知进行评估。
方法/主要发现:该研究纳入了所有被Medline收录的76种意大利期刊以及76种随机选取的英国期刊;仅研究在这些国家编辑和出版的期刊。与英国期刊相比,意大利期刊发表的论文数量更少(中位数分别为60篇和93篇;p = 0.006),拥有在线存档的情况更少(43种对74种;p<0.001),影响因子的中位数更低(1.2对2.7,p<0.001),以及Scimago期刊排名更低(0.09对0.25,p<0.001)。在编辑领导力方面,意大利期刊较少要求稿件注明竞争利益(p<0.001)、作者贡献(p = 0.005)、资金来源(p<0.001)、知情同意(p<0.001)、伦理委员会审查(p<0.001)。没有意大利期刊遵循COPE或CONSORT及QUOROM声明,也不要求进行临床试验注册,而这些情况在15% - 43%的英国期刊中存在(p<0.001)。在多元回归分析中,编辑领导力预测了由引用统计定义的期刊质量方差的37.1% - 49.9%(p<0.0001);跨文化比较中固有的混杂变量贡献相对较小,额外解释了方差的6.2% - 13.8%。
结论/意义:意大利的期刊在质量和编辑领导力方面得分低于英国同行。编辑领导力预测了所有期刊的质量。更重视旨在改善生物医学报告的国际倡议可能有助于低质量期刊提升地位。